SEARCH

SEARCH BY CITATION

References

  • Gouw, S.C. (2005) The concerted action on neutralizing antibodies in severe haemophilia A (canal study): preliminary findings. Journal of Thrombosis and Haemostasis, 3(Suppl. 1), OR093 (abstract).
  • Morado, M., Villar, A., Jimenez Yuste, V., Quintana, M. & Hernandez Navarro, F. (2005) Prophylactic treatment effects on inhibitor risk: experience in one centre. Haemophilia, 11, 7983.
  • Santagostino, E., Mancuso, M.E., Rocino, A., Mancuso, G., Mazzucconi, M.G., Tagliaferri, A., Messina, M. & Mannucci, P.M. (2005) Environmental risk factors for inhibitor development in children with haemophilia A. A case–control study. British Journal of Haematology, 130, 422427.
  • Stobart, K., Iorio, A. & Wu, J.K. (2005) Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database of Systematic Reviews, 18, CD003429.